MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in VIR — Vir Biotechnology, Inc.

CIK 912938 Boston, MA

Position in VIR

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$901,885

+$311,041 QoQ

Shares Held

88,507

+40.4% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 237 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 84% Shared 16% None 0%

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. VIR ranks #37 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	1,875,301	$500,180,281
2	RVMD	Revolution Medicines, Inc.	2,012,317	$376,866,725
3	VRTX	Vertex Pharmaceuticals Inc / Ma	423,049	$210,141,127
4	TECH	BIO-TECHNE Corp	2,746,462	$194,037,538
5	SRRK	Scholar Rock Holding Corp	2,607,348	$143,404,140
6	LGND	Ligand Pharmaceuticals Inc	375,762	$118,774,610
7	ALNY	Alnylam Pharmaceuticals, Inc.	350,560	$105,529,075
8	BNTX	BioNTech SE	677,708	$63,060,728

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$901,885	88,507	+40.4%	Shares	Defined	2026-08-03
2023-09-30	$590,844	63,057	-3.7%	Shares	Sole	2023-11-08
2023-06-30	$1,606,077	65,474	-2.3%	Shares	Sole	2023-08-09
2023-03-31	$1,559,462	67,016	-37.3%	Shares	Sole	2023-05-10
2022-12-31	$2,707,258	106,964	+2.2%	Shares	Sole	2023-02-13
2022-09-30	$2,018,750	104,707	-0.9%	Shares	Sole	2022-11-09
2022-06-30	$2,691,287	105,665	+0.5%	Shares	Sole	2022-08-09
2022-03-31	$2,703,892	105,128	+421.7%	Shares	Sole	2022-05-11
2021-03-31	$1,033,193	20,152	-62.3%	Shares	Sole	2021-05-13
2020-12-31	$1,432,381	53,487	+49.6%	Shares	Sole	2021-05-12
2020-09-30	$1,227,160	35,746	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.